Bergman, Correa Lead Letter Urging FDA to Expedite Review of Breakthrough Mental Health Therapies
agency to advance its evaluation of rapid-acting novel therapeutics – including entactogen- and psychedelic-assisted therapies … Administration’s (FDA) ongoing evaluation of rapid-acting novel therapeutics, including entactogen- and psychedelic-assisted therapies, for mental